Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | PTGES2 | Q9H7Z7 | 7/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.40 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SLC40A1 | Q9NP59 | 1/20 | 0.39 |
| ▸ | CCR4 | P51679 | 2/20 | 0.38 |
| ▸ | GHSR | Q92847 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10453953 | 0.82 | ALDH1A1 (0.77) | ALDH1A1L3MBTL1PTGES2TSHRMCOLN3 | |
| SCHEMBL4031272 | 0.79 | ALDH1A1 (0.66) | ALDH1A1L3MBTL1PTGES2TSHRMCOLN3 | |
| SCHEMBL810171 | 0.77 | NPY5R (0.63) | ALDH1A1L3MBTL1NPY5RMCOLN3LMNA | |
| SCHEMBL810572 | 0.76 | ALDH1A1 (0.50) | ALDH1A1PGRLMNAGAASMN1; SMN2 | |
| SCHEMBL810008 | 0.75 | MAPK1 (0.59) | ALDH1A1TSHRMCOLN3LMNAGAA | |
| SCHEMBL810835 | 0.74 | ALDH1A1 (0.53) | ALDH1A1TSHRMCOLN3LMNAGAA | |
| SCHEMBL14455217 | 0.74 | ALDH1A1 (0.65) | ALDH1A1MCOLN3LMNAGAASMN1; SMN2 | |
| SCHEMBL5796406 | 0.74 | ALDH1A1 (0.65) | ALDH1A1MCOLN3LMNAGAASMN1; SMN2 | |
| SCHEMBL6055248 | 0.74 | ALDH1A1 (0.65) | ALDH1A1MCOLN3LMNAGAASMN1; SMN2 | |
| SCHEMBL810500 | 0.74 | ALDH1A1 (0.38) | ALDH1A1L3MBTL1TSHRMCOLN3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2399895-B1 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-8558033-B2 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2013-10-15 | — | — | US | disclosed |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2399895-A2 | Process for producing optically active aliphatic fluoroalcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2011-12-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | ADH1A, ADH1C, ADH5 | ALDH1A1 5/4885L3MBTL1 3637/4885PTGES2 3252/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.